SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE: KCI) has announced the first patient placement of the company’s innovative V.A.C.® ATS Therapy System in Japan. This landmark event represents the commercial launch of the therapy in Japan and the beginning of a comprehensive market development strategy in the country. V.A.C.® Therapy has treated more than three million patients in more than 50 countries worldwide and has been clinically proven in 20 randomized controlled trials and more than 550 peer-reviewed articles.
